The Reproductive Infectious Diseases Program is a network of health professionals, researchers and knowledge users dedicated to advancing reproductive infectious diseases care and research internationally. Through local, national and global research collaborations, the team works to address emergent knowledge gaps and provide evidence-based guidance for the prevention, treatment, and care of reproductive infectious diseases. An overview of the program and the research we do can be found here. 

Latest Updates from the RID Program:

...

New Report Released from the RID Program’s CANCOVID-Preg Project!

The RID Program’s Canadian Surveillance of COVID-19 in Pregnancy: Epidemiology, Maternal and Infant Outcomes (CANCOVID-Preg) Project has just released a new report (Report #7) on some of the most recent updates, key findings and recommendations based on the latest data. This project has been led by Dr. Deborah Money and the rest of the RID Program team, as well as a team of national collaborators since April of 2020, to better understand the epidemiology and infant/maternal outcomes associated with COVID-19 infection in pregnancy.

For more information, Click here to access the report!

...

Register Now for the International Workshop on HIV & Women 2025!

Registration is now open for the 2025 iteration of the annual International Workshop on Women & HIV, which is being held from April 11-12, 2025 in Barcelona, Spain as well as virtually!

This workshop provides an exciting opportunity for experts in the research, treatment and care of women living with HIV from around the world, to meet and discuss the latest developments in the treatment and care of HIV in women and future areas of medical research.

Click here to get more information on the conference, and to register click here!

Highlighted Research

NOVA-HIV

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV

The goal of this study is to explore reduced dosing of the nonavalent HPV vaccine in women living with HIV. This multi-site phase IV clinical trial will carry on from our previous HPV in HIV studies. Recruitment began in late 2023 and is currently ongoing.

REACT-Syph

Towards the Eradication of Congenital Syphilis in Canada (REACT-Syph): Canadian Maternal and Congenital Syphilis Surveillance

In order to combat the rising rates of syphilis in pregnancy and congenital syphilis and create evidence-based prevention strategies, we need a better understanding of the circumstances surrounding infections and why diagnosis and treatment in pregnant women is not happening consistently across the country. As part of this project, we are creating a pan-Canadian syphilis in pregnancy surveillance program that includes cases from 2013-present. This surveillance system will build on established infrastructure and relationships to characterize cases of antenatal syphilis, including cases that result in congenital syphilis, identify barriers to care and gaps in current prevention strategies, and inform future interventions.

RECOVERED: Vaccine Registry for 2024 Pregnancies

Respiratory Syncytial Virus (RSV) Vaccine and Monoclonal Antibody Treatment in Canadian Pregnant Individuals and their Infants (RECOVERED): An Evaluation of Acceptability, Safety, and Efficacy

The RECOVERED Project is a Canada-wide project being conducted by the UBC Reproductive Infectious Diseases Program and is investigating Respiratory Syncytial Virus (RSV) Vaccines in pregnancy. The RECOVERED project aims to broaden our understanding of vaccine attitudes, pregnancy outcomes, and infant outcomes related to maternal vaccination and infant monoclonal antibody treatment for RSV.